Cargando…
Peroxiredoxin2 downregulation enhances hepatocellular carcinoma proliferation and migration, and is associated with unfavorable prognosis in patients
It has been revealed by our previous proteomic study that the expression profile is different between well-differentiated and poorly differentiated hepatocellular carcinoma (HCC). Among those differently expressed proteins, peroxiredoxin2 (PRDX2) was our protein of interest. The present study aimed...
Autores principales: | Bai, Bing, Lin, Yanyan, Hu, Jinjing, Wang, Haiping, Li, Lu, Zhao, Sheng, Zhang, Jinduo, Meng, Wenbo, Yue, Ping, Bai, Zhongtian, Li, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365706/ https://www.ncbi.nlm.nih.gov/pubmed/30747220 http://dx.doi.org/10.3892/or.2019.6977 |
Ejemplares similares
-
Curcumol Exerts Anticancer Effect in Cholangiocarcinoma Cells via Down-Regulating CDKL3
por: Zhang, Jinduo, et al.
Publicado: (2018) -
Downregulation of GNA14 in hepatocellular carcinoma indicates an unfavorable prognosis
por: Yu, Tao, et al.
Publicado: (2020) -
Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients
por: Zhou, Zhong‐Guo, et al.
Publicado: (2020) -
Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma
por: Shi, Jie, et al.
Publicado: (2021) -
Downregulated expression of CFHL1 is associated with unfavorable prognosis in postoperative patients with hepatocellular carcinoma
por: Feng, Hao, et al.
Publicado: (2019)